SciVision Biotech Inc (1786) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.007x

Based on the latest financial reports, SciVision Biotech Inc (1786) has a cash flow conversion efficiency ratio of -0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-13.02 Million ≈ $-410.33K USD) by net assets (NT$1.98 Billion ≈ $62.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SciVision Biotech Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

SciVision Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how SciVision Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SciVision Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SciVision Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Energy World Corporation Ltd AU:EWC	-0.017x
Siam Wellness Group Public Company Limited BK:SPA	0.119x
Humanica Public Company Limited BK:HUMAN	0.044x
Alpha Cognition Inc NASDAQ:ACOG	-0.158x
Count Ltd AU:CUP	0.106x
ASolid Technology Co Ltd TWO:6485	0.027x
GTS Internasional Tbk PT JK:GTSI	0.175x
ezCaretech Co. LTD KQ:099750	0.190x

Annual Cash Flow Conversion Efficiency for SciVision Biotech Inc (2009–2025)

The table below shows the annual cash flow conversion efficiency of SciVision Biotech Inc from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see SciVision Biotech Inc (1786) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.98 Billion ≈ $62.39 Million	NT$123.99 Million ≈ $3.91 Million	0.063x	-55.99%
2024-12-31	NT$1.90 Billion ≈ $59.77 Million	NT$269.87 Million ≈ $8.50 Million	0.142x	-14.94%
2023-12-31	NT$1.63 Billion ≈ $51.24 Million	NT$272.01 Million ≈ $8.57 Million	0.167x	+41.79%
2022-12-31	NT$1.51 Billion ≈ $47.60 Million	NT$178.21 Million ≈ $5.61 Million	0.118x	+73.60%
2021-12-31	NT$1.45 Billion ≈ $45.68 Million	NT$98.51 Million ≈ $3.10 Million	0.068x	-24.57%
2020-12-31	NT$1.40 Billion ≈ $44.24 Million	NT$126.47 Million ≈ $3.98 Million	0.090x	-40.04%
2019-12-31	NT$1.36 Billion ≈ $42.87 Million	NT$204.40 Million ≈ $6.44 Million	0.150x	+44.98%
2018-12-31	NT$1.08 Billion ≈ $33.97 Million	NT$111.70 Million ≈ $3.52 Million	0.104x	+492.97%
2017-12-31	NT$914.45 Million ≈ $28.81 Million	NT$15.98 Million ≈ $503.39K	0.017x	-59.19%
2016-12-31	NT$894.21 Million ≈ $28.17 Million	NT$38.29 Million ≈ $1.21 Million	0.043x	-18.46%
2015-12-31	NT$948.60 Million ≈ $29.89 Million	NT$49.81 Million ≈ $1.57 Million	0.053x	+2800.57%
2014-12-31	NT$1.02 Billion ≈ $32.23 Million	NT$1.85 Million ≈ $58.35K	0.002x	-94.74%
2013-12-31	NT$1.08 Billion ≈ $34.15 Million	NT$37.27 Million ≈ $1.17 Million	0.034x	-71.56%
2012-12-31	NT$425.98 Million ≈ $13.42 Million	NT$51.52 Million ≈ $1.62 Million	0.121x	+18.47%
2011-12-31	NT$363.70 Million ≈ $11.46 Million	NT$37.13 Million ≈ $1.17 Million	0.102x	+66.58%
2010-12-31	NT$111.73 Million ≈ $3.52 Million	NT$6.85 Million ≈ $215.72K	0.061x	+114.28%
2009-12-31	NT$84.09 Million ≈ $2.65 Million	NT$-36.09 Million ≈ $-1.14 Million	-0.429x	--

About SciVision Biotech Inc

TW:1786 Taiwan Medical Instruments & Supplies

Market Cap

$127.07 Million

NT$4.03 Billion TWD

Market Cap Rank

#18380 Global

#996 in Taiwan

Share Price

NT$53.90

Change (1 day)

-0.74%

52-Week Range

NT$51.50 - NT$123.00

All Time High

NT$136.50